The effect of raloxifene in association with vitamin D on vaginal maturation index and urogenital symptoms in postmenopausal osteoporotic women.
In elderly women with osteoporosis, raloxifene treatment with vitamin D supplementation improves vaginal maturation index and vaginal pH.
Zeyneloglu
Hulusi B
HB
Department of Obstetrics and Gynecology, Baskent University, Faculty of Medicine, Ankara, Turkey. hnzeynelog@e-kolay.net <hnzeynelog@e-kolay.net>
Oktem
Mesut
M
Haberal
Nihan A
NA
Esinler
Ibrahim
I
Kuscu
Esra
E
D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000494:pharmacology; D004338:Drug Combinations; D015914:Estrogen Replacement Therapy; D005260:Female; D052776:Female Urogenital Diseases / Q000517:prevention & control*; D006305:Health Status Indicators; D006801:Humans; D006863:Hydrogen-Ion Concentration / Q000187:drug effects; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000188:drug therapy*; D020849:Raloxifene Hydrochloride / Q000008:administration & dosage* / Q000494:pharmacology*; D014621:Vagina / Q000166:cytology / Q000187:drug effects*; D014626:Vaginal Smears; D014807:Vitamin D / Q000008:administration & dosage* / Q000494:pharmacology*
D050071:Bone Density Conservation Agents; D004338:Drug Combinations; D014807:Vitamin D; D020849:Raloxifene Hydrochloride